Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,514 | 84 | 94.6% |
| Education | $142.82 | 1 | 5.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $884.72 | 28 | $0 (2023) |
| Biosense Webster, Inc. | $489.93 | 5 | $0 (2024) |
| Medtronic Vascular, Inc. | $251.22 | 4 | $0 (2018) |
| AtriCure, Inc. | $157.75 | 2 | $0 (2018) |
| Actelion Pharmaceuticals US, Inc. | $135.71 | 6 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $108.78 | 7 | $0 (2022) |
| Boston Scientific Corporation | $107.58 | 6 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $80.13 | 5 | $0 (2024) |
| Medtronic, Inc. | $69.37 | 1 | $0 (2024) |
| PFIZER INC. | $47.41 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $553.82 | 12 | Biosense Webster, Inc. ($320.19) |
| 2023 | $147.44 | 6 | Abbott Laboratories ($50.88) |
| 2022 | $208.28 | 7 | Abbott Laboratories ($122.21) |
| 2021 | $357.39 | 19 | Abbott Laboratories ($114.95) |
| 2020 | $265.98 | 11 | Abbott Laboratories ($159.80) |
| 2019 | $122.31 | 6 | Abbott Laboratories ($110.35) |
| 2018 | $659.88 | 14 | Medtronic Vascular, Inc. ($251.22) |
| 2017 | $341.31 | 10 | Abbott Laboratories ($326.53) |
All Payment Transactions
85 individual payment records from CMS Open Payments — Page 2 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/28/2021 | Abbott Laboratories | Confirm Rx (Device) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/19/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/16/2021 | Abbott Laboratories | Quadra Allure MP RF CRT Pacemkr (Device) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/01/2021 | Abbott Laboratories | Confirm Rx (Device) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/23/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.31 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/17/2021 | Abbott Laboratories | Confirm Rx (Device) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/02/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/29/2021 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Cardiology | ||||||
| 09/23/2021 | Abbott Laboratories | Confirm Rx (Device) | Food and Beverage | In-kind items and services | $30.92 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/15/2021 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological), EVKEEZA | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 09/07/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/27/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: Diabetes | ||||||
| 07/14/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/06/2021 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Cardiology | ||||||
| 06/22/2021 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $28.81 | General |
| Category: Genetic Disease | ||||||
| 06/16/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/15/2021 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological), EVKEEZA | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 06/10/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Cardiology | ||||||
| 03/01/2021 | Abbott Laboratories | Merlin Connectivity and Remote (Device) | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/12/2020 | Abbott Laboratories | Confirm Rx (Device) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/03/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Cardiology | ||||||
| 10/28/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Cardiology | ||||||
| 10/21/2020 | Abbott Laboratories | Confirm Rx (Device) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 10/14/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.62 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/13/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,732 | 2,730 | $361,304 | $99,169 |
| 2022 | 23 | 1,968 | 2,963 | $401,515 | $120,296 |
| 2021 | 35 | 2,321 | 3,389 | $540,956 | $164,023 |
| 2020 | 29 | 2,610 | 3,445 | $466,078 | $130,939 |
All Medicare Procedures & Services
114 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 229 | 503 | $99,091 | $11,619 | 11.7% |
| 33249 | Insertion of implantable defibrillator system | Facility | 2023 | 16 | 16 | $29,760 | $11,120 | 37.4% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 299 | 664 | $33,200 | $9,007 | 27.1% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 108 | 140 | $21,700 | $8,843 | 40.7% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 12 | 12 | $21,672 | $8,813 | 40.7% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 87 | 123 | $20,541 | $8,540 | 41.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 109 | 124 | $13,665 | $7,484 | 54.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 75 | $12,000 | $6,584 | 54.9% |
| 33225 | Insertion of left lower heart electrode for pacemaker or defibrillator | Facility | 2023 | 14 | 14 | $13,538 | $4,904 | 36.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 76 | 166 | $10,126 | $3,303 | 32.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 47 | 66 | $14,256 | $3,299 | 23.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 50 | $6,300 | $2,974 | 47.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 212 | 257 | $19,789 | $2,498 | 12.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 47 | 47 | $12,455 | $2,374 | 19.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $3,283 | $1,477 | 45.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 214 | 293 | $6,739 | $1,467 | 21.8% |
| 93281 | Programming of multiple lead pacemaker system | Office | 2023 | 21 | 28 | $6,300 | $1,462 | 23.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 22 | 22 | $4,136 | $1,130 | 27.3% |
| 93282 | Programming of single lead implantable defibrillator system | Office | 2023 | 18 | 24 | $2,928 | $1,116 | 38.1% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 22 | 22 | $1,056 | $385.14 | 36.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 25 | 25 | $4,175 | $244.39 | 5.9% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 21 | 21 | $630.00 | $187.74 | 29.8% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 13 | 13 | $2,548 | $175.03 | 6.9% |
| 93225 | Electrocardiogram (ecg) 2-day continuous | Office | 2023 | 12 | 12 | $1,416 | $163.44 | 11.5% |
| 33249 | Insertion of implantable defibrillator system | Facility | 2022 | 22 | 22 | $40,920 | $16,058 | 39.2% |
About Dr. Joel Reinoehl, MD
Dr. Joel Reinoehl, MD is a Cardiovascular Disease healthcare provider based in Kalamazoo, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326068347.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joel Reinoehl, MD has received a total of $2,656 in payments from pharmaceutical and medical device companies, with $553.82 received in 2024. These payments were reported across 85 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,514).
As a Medicare-enrolled provider, Reinoehl has provided services to 8,631 Medicare beneficiaries, totaling 12,527 services with total Medicare billing of $514,426. Data is available for 4 years (2020–2023), covering 114 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location Kalamazoo, MI
- Active Since 07/20/2006
- Last Updated 08/23/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1326068347
Products in Payments
- CARTO 3 (Device) $320.19
- Confirm Rx (Device) $218.97
- CRT-Ds (Device) $195.52
- Carto 3 System (Device) $169.74
- Azure (Device) $143.73
- CONFIRM RX (Device) $122.21
- OPSUMIT (Drug) $112.35
- AtriCure AtriClip LAA Exclusion System (Device) $110.04
- ENTRESTO (Drug) $108.78
- Reveal LINQ (Device) $94.05
- LifeVest (Device) $80.13
- Merlin Connectivity and Remote (Device) $78.58
- COBALT DR MRI SURESCAN (Device) $69.37
- ICDs (Device) $67.84
- WATCHMAN FLX (Device) $53.16
- Assurity Pacemaker (Device) $49.82
- Pacemakers (Device) $49.11
- ELIQUIS (Drug) $48.19
- Epi-Sense Guided Coagulation System with VisiTrax, Models (Device) $47.71
- PRALUENT (Biological) $40.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Kalamazoo
Dr. Vishal Gupta, M.d, M.D
Cardiovascular Disease — Payments: $423,224
Dr. Anthony King
Cardiovascular Disease — Payments: $66,639
Dr. Robert Williams, D.o, D.O
Cardiovascular Disease — Payments: $55,563
Dr. Christopher Rogers, D.o, D.O
Cardiovascular Disease — Payments: $34,998
Frank Saltiel, M.d, M.D
Cardiovascular Disease — Payments: $29,179
Michael Pack, Do, DO
Cardiovascular Disease — Payments: $28,931